抗体诱导的纯红细胞再生障碍性贫血后重组人促红细胞生成素的成功重新引入。 - Suppr

Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia.

作者信息

Summers Shaun A, Matijevic Ante, Almond Mike K

机构信息

Renal Medicine, Southend General Hospital, Westcliff-on-Sea, Essex, UK.

出版信息

Nephrol Dial Transplant. 2004 Aug;19(8):2137-9. doi: 10.1093/ndt/gfh319.

DOI:10.1093/ndt/gfh319

PMID:15252175

Abstract

摘要

相似文献

Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia.

Nephrol Dial Transplant. 2004 Aug;19(8):2137-9. doi: 10.1093/ndt/gfh319.

Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs.

Nephrol Dial Transplant. 2008 Jul;23(7):2416-8. doi: 10.1093/ndt/gfn051. Epub 2008 Apr 3.

Antibody-mediated acquired pure red cell aplasia (PRCA) after treatment with darbepoetin.

Nephrol Dial Transplant. 2007 May;22(5):1462-4. doi: 10.1093/ndt/gfl727. Epub 2007 Feb 21.

Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent.

Nephrol Dial Transplant. 2006 Oct;21(10):2963-5. doi: 10.1093/ndt/gfl331. Epub 2006 Jul 20.

Epoetin-induced autoimmune pure red cell aplasia.

Hematol J. 2004;5 Suppl 3:S104-9. doi: 10.1038/sj.thj.6200433.

Pure red cell aplasia secondary to epoetin alpha responding to Darbepoetin alpha in a patient on peritoneal dialysis.

J Am Soc Nephrol. 2004 Aug;15(8):2204-7. doi: 10.1097/01.ASN.0000135056.81056.A4.

Re-challenging patients who developed pure red cell aplasia with epoetin: can it be done?

Nephrol Dial Transplant. 2004 Nov;19(11):2901-5. doi: 10.1093/ndt/gfh368.

Pure red cell aplasia caused by antibody to erythropoietin successfully treated by cyclosporine administration.

Am J Hematol. 2007 Mar;82(3):247-8. doi: 10.1002/ajh.20740.

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

N Engl J Med. 2002 Feb 14;346(7):469-75. doi: 10.1056/NEJMoa011931.

Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient.

BMC Nephrol. 2020 Jul 14;21(1):275. doi: 10.1186/s12882-020-01934-2.

引用本文的文献

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients.

J Nephropathol. 2017 Jan;6(1):25-29. doi: 10.15171/jnp.2017.05. Epub 2016 Aug 22.

Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously.

J Korean Med Sci. 2010 Nov;25(11):1676-9. doi: 10.3346/jkms.2010.25.11.1676. Epub 2010 Oct 26.

Anti-erythropoietin antibodies followed by endogenous erythropoietin production in a dialysis patient.

Pediatr Nephrol. 2010 May;25(5):971-6. doi: 10.1007/s00467-009-1406-4. Epub 2010 Jan 21.

Drug-induced hematologic syndromes.

Adv Hematol. 2009;2009:495863. doi: 10.1155/2009/495863. Epub 2009 Jul 7.

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.

Blood. 2005 Nov 15;106(10):3343-7. doi: 10.1182/blood-2005-02-0508. Epub 2005 Aug 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献